Crossref
journal-article
Elsevier BV
Current Opinion in Solid State and Materials Science (78)
References
49
Referenced
1,046
10.1111/j.1768-322X.1987.tb00571.x
/ Biol Cell / Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine by Aprahamian (1987)10.1016/S0168-3659(00)00339-4
/ J. Control. Release / Biodegradable polymeric nanoparticles as drug delivery devices by Soppimath (2001)10.1023/A:1012029517394
/ Pharm. Res. / The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual by Florence (1997)10.1016/S0169-409X(01)00184-3
/ Adv. Drug Deliv. Rev. / Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas by Florence (2001)10.1016/S0378-5173(00)00364-1
/ Int. J. Pharm. / Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer’s patch segment by Torche (2000)10.1016/S0168-3659(97)00241-1
/ J. Control. Release / Polymeric nanoparticles as delivery system for influenza virus glycoproteins by Lemoine (1998)10.1016/S0939-6411(97)00056-8
/ Eur. J. Pharm. Biopharm. / Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres by Blanco (1997)10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L
/ J. Biomed. Mater. Res. / Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres by Suh (1998)10.1016/S0168-3659(96)01484-8
/ J. Control. Release / Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery by Song (1997)10.1016/S0168-3659(98)00056-X
/ J. Control. Release / A poly(d,l-lactide-co-glycolide) microsphere depot system for delivery of haloperidol by Cheng (1998)10.1016/S0168-3659(00)00364-3
/ J. Control. Release / Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers by Feng (2001)10.1016/S0168-3659(01)00486-2
/ J. Control. Release / Design of biodegradable particles for protein delivery by Vila (2002)10.1016/S0168-3659(96)01475-7
/ J. Control. Release / Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics by Rafati (1997)10.1016/S0168-3659(01)00218-8
/ J. Control. Release / PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats by Li (2001)10.1016/S0168-3659(99)00247-3
/ J Control Release / Nanosphere based oral insulin delivery by Carino (2000)10.1016/S0927-7757(00)00825-6
/ Colloids Surf / Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method by Kwon (2001)10.1016/S0169-409X(00)00120-4
/ Adv Drug Deliv / Mucoadhesive nanoparticulate systems for peptide drug delivery by Takeuchi (2001)10.1016/S0168-3659(98)00116-3
/ J Control Release / PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug by Govender (1999)10.1016/S0378-5173(99)00187-8
/ Int J Pharm / Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method by Murakami (1999)10.1016/S0939-6411(98)00015-0
/ Eur J Pharm Biopharm / Preparation and characterization of nanoparticles containing an antihypertensive agent by Verger (1998)10.1016/0168-3659(95)00164-6
/ J Control Release / Biodegradable nanoparticles-from sustained release formulations to improved site specific drug delivery by Leroux (1996)10.1016/S0169-409X(00)00119-8
/ Adv Drug Deliv / Design of nanoparticles composed of graft copolymers for oral peptide delivery by Sakuma (2001)10.1016/S0142-9612(00)00286-6
/ Biomaterials / Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation by Behan (2001)10.1016/S0169-409X(00)00123-X
/ Adv Drug Deliv / Polysaccharide colloidal particles as delivery systems for macromolecules by Janes (2001)-
Hu Y. et al. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials, in press.
(
10.1016/S0142-9612(02)00071-6
) 10.1016/S0142-9612(97)00246-9
/ Biomaterials / Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles by Fontana (1998)10.1016/S0928-0987(98)00066-9
/ Eur J Pharm Sci / Stability and freeze-drying of cyclosporine loaded poly(d,l-lactide-glycolide) carriers by Chacon (1999)10.1016/S0939-6411(00)00125-9
/ Eur J Pharm Biopharm / Freeze-drying of polycarolactone and poly(d,l-lactic-glycolic) nanoparticles induces minor particle size changes affecting the oral pharmacokinetics of loaded drugs by Saez (2000)10.1016/S0169-409X(00)00122-8
/ Adv Drug Deliv / Nanoparticulate systems for brain delivery of drugs by Kreuter (2001)10.1016/S0168-3659(01)00519-3
/ J Control Release / Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles by Arias (2001)10.1016/S0142-9612(01)00030-8
/ Biomaterials / Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake by Fontana (2001)10.1016/S0168-3659(00)00201-7
/ J Control Release / Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres by Jung (2000)10.1016/S0168-3659(00)00280-7
/ J Control Release / In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates by Yoo (2000)10.1016/S0378-5173(00)00632-3
/ Int J Pharm / Design of triptorelin loaded nanospheres for transdermal iontophoretic administration by Nicoli (2001)10.1016/S0169-409X(00)00118-6
/ Adv Drug Deliv / Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future by Muller (2001)10.1016/S0927-7765(99)00156-3
/ Colloids Surf B / ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption by Gref (2000)10.1016/S0927-7765(99)00157-5
/ Colloids Surf B / The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration by Tobio (2000)10.1016/S0168-3659(99)00063-2
/ J Control Release / Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting by Peracchia (1999)10.1016/S0378-5173(01)00676-7
/ Int J Pharm / Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles by Panagi (2001)10.1016/S0168-3659(00)00367-9
/ J Control Release / Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterization and in vivo evaluation by Redhead (2001)10.1016/S0168-3659(99)00244-8
/ J Control Release / Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis by Fishbein (2000)10.1016/S0168-3659(98)00016-9
/ J Control Release / Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model by Song (1998)10.1016/S0169-409X(00)00121-6
/ Adv Drug Deliv / Lymphatic targeting with nanoparticulate system by Nishioka (2001)10.1016/S0169-409X(00)00116-2
/ Adv Drug Deliv / Nanoparticulate systems for the delivery of antisense oligonucleotides by Lambert (2001)10.1016/S0168-3659(01)00397-2
/ J Control Release / Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA by Perez (2001)10.1016/S0169-409X(01)00171-5
/ Adv Drug Deliv Rev / Chitosan as a novel nasal delivery system for vaccines by Illum (2001)10.1016/S0378-5173(01)00760-8
/ Int J Pharm / Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A by DeCampos (2001)10.1016/S0378-5173(99)00153-2
/ Int J Pharm / Preparation of nanoparticles consisted of poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) and their evolution in vitro by Matsumoto (1999)10.1016/S0168-3659(01)00530-2
/ J Control Release / PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vivo drug release and in vivo drug residence in blood properties by Avgoustakis (2002)
Dates
Type | When |
---|---|
Created | 22 years, 8 months ago (Dec. 27, 2002, 10:52 a.m.) |
Deposited | 6 years, 4 months ago (April 8, 2019, 1:51 a.m.) |
Indexed | 1 week ago (Aug. 29, 2025, 5:53 a.m.) |
Issued | 23 years, 1 month ago (Aug. 1, 2002) |
Published | 23 years, 1 month ago (Aug. 1, 2002) |
Published Print | 23 years, 1 month ago (Aug. 1, 2002) |
@article{Hans_2002, title={Biodegradable nanoparticles for drug delivery and targeting}, volume={6}, ISSN={1359-0286}, url={http://dx.doi.org/10.1016/s1359-0286(02)00117-1}, DOI={10.1016/s1359-0286(02)00117-1}, number={4}, journal={Current Opinion in Solid State and Materials Science}, publisher={Elsevier BV}, author={Hans, M.L and Lowman, A.M}, year={2002}, month=aug, pages={319–327} }